ZNF420 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.407620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.411200E-01
Normal-vs-Stage2
8.962100E-02
Normal-vs-Stage3
3.224200E-02
Normal-vs-Stage4
6.939600E-01
Stage1-vs-Stage2
6.349900E-02
Stage1-vs-Stage3
6.130000E-02
Stage1-vs-Stage4
8.526000E-01
Stage2-vs-Stage3
1.561360E-01
Stage2-vs-Stage4
2.235400E-01
Stage3-vs-Stage4
7.778400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.456830E-01
Normal-vs-AfricanAmerican
5.283400E-01
Normal-vs-Asian
2.862500E-02
Caucasian-vs-AfricanAmerican
4.086600E-01
Caucasian-vs-Asian
1.120220E-01
AfricanAmerican-vs-Asian
8.626400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.152620E-01
Normal-vs-Female
1.932770E-01
Male-vs-Female
4.158800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.383200E-01
Normal-vs-Age(41-60Yrs)
2.782000E-01
Normal-vs-Age(61-80Yrs)
1.069970E-01
Normal-vs-Age(81-100Yrs)
2.774100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.292400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.317600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.557800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.592300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.200000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.749800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.189690E-02
Normal-vs-Daily Drinker
1.280480E-02
Normal-vs-Weekly Drinker
3.979600E-02
Normal-vs-Occasional Drinker
2.431400E-01
Normal-vs-Social Drinker
6.506400E-01
Non Drinker-vs-Daily Drinker
9.678200E-01
Non Drinker-vs-Weekly Drinker
8.160000E-01
Non Drinker-vs-Occasional Drinker
3.478500E-02
Non Drinker-vs-Social Drinker
5.030000E-02
Daily Drinker-vs-Weekly Drinker
8.466200E-01
Daily Drinker-vs-Occasional Drinker
4.944300E-02
Daily Drinker-vs-Social Drinker
5.412000E-02
Weekly Drinker-vs-Occasional Drinker
1.358010E-01
Weekly Drinker-vs-Social Drinker
8.275600E-02
Occasional Drinker-vs-Social Drinker
4.749800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.720980E-01
Normal-vs-Grade 2
8.709800E-02
Normal-vs-Grade 3
6.256300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.723200E-01
Grade 1-vs-Grade 3
5.793200E-01
Grade 1-vs-Grade 4
1.720980E-01
Grade 2-vs-Grade 3
9.844000E-01
Grade 2-vs-Grade 4
8.709800E-02
Grade 3-vs-Grade 4
6.256300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.592000E-02
Normal-vs-NonDiabetic
1.046560E-01
Diabetic-vs-NonDiabetic
6.049200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.654200E-02
Normal-vs-NoPancreatitis
1.184220E-01
Pancreatitis-vs-NoPancreatitis
8.125700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.201000E-01
Normal-vs-N1
1.018570E-01
N0-vs-N1
9.951200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.629640E-01
Normal-vs-TP53-NonMutant
5.686600E-01
TP53-Mutant-vs-TP53-NonMutant
5.751900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
